Mania induced by lithium augmentation. A case report

Yuvarajan, R.; Yousufzai, N. M.
December 1988
British Journal of Psychiatry;Dec88, Vol. 153, p828
Academic Journal
journal article
A case of mania subsequent to the addition of lithium in unsuccessful treatment by antidepressants is presented. It is suggested that lithium might potentiate some properties of antidepressants which affect their capacity to induce mania.


Related Articles

  • Double-blind study of imipramine versus phenelzine in Melancholias and Dysthymic Disorders. Vallejo, J.; Gasto, C.; Catalan, R.; Salamero, M. // British Journal of Psychiatry;Nov87, Vol. 151, p639 

    In a 6-week double-blind trial, the efficacy of imipramine and high dose phenelzine were compared in the treatment of Major Depression with Melancholia, and Dysthymic Disorder (DSM-III). Both drugs were found to be equally efficacious in the treatment of 32 patients suffering from Major...

  • Controlled studies of the acute antidepressant effects of lithium. Worrall, E. P.; Moody, J. P.; Peet, M.; Dick, P.; Smith, A.; Chambers, C.; Adams, M.; Naylor, G. J. // British Journal of Psychiatry;Sep79, Vol. 135, p255 

    In two randomized double-blind controlled trials on 63 depressed female in-patients subject to recurrent affective disorder (bipolar and unipolar manic-depressive psychosis) lithium was shown to have major acute antidepressant effects. At the end of three weeks lithium produced more uniform...

  • Lithium augmentation in antidepressant-resistant patients. A quantitative analysis. Austin, M.-P.V.; Souza, F.G.M.; Goodwin, G.M.; Austin, M P; Souza, F G // British Journal of Psychiatry;Oct91, Vol. 159, p510 

    A quantitative analysis was used to examine the efficacy of lithium augmentation in the acute treatment of depressed patients resistant to a standard trial of an antidepressant. Effect sizes were measured by the odds ratio using the Mantel-Haenszel method. Only controlled trials were included in...

  • Nefazodone in Psychotic Unipolar and Bipolar Depression: A Retrospective Chart Analysis and Open Prospective Study on Its Efficacy and Safety versus Combined Treatment with Amitriptyline and Haloperidol. Grunze, Heinz; Marcuse, Alain; Schärer, Lars O.; Born, Christoph; Walden, Jörg // Neuropsychobiology;2002 Supplement 1, Vol. 46, p31 

    Although atypical antipsychotics are on the rise, traditional treatment of psychotic (or delusional) depression mostly includes the addition of classical antipsychotics to antidepressants. As there are only few data supporting this approach compared with antidepressant monotherapy, and almost no...

  • Post-stroke emotional incontinence or bipolar disorder? Mnif, Leila; Sellami, Rim; Masmoudi, Jawaher // Neuropsychiatric Disease & Treatment;Jul2016, Vol. 12, p1883 

    Introduction: Post-stroke emotional incontinence and bipolar disorder are two disorders that involve the dysfunction of brain structures responsible for emotional regulation. The objective of this work is to study the links between these disorders through a clinical case. Case report: We present...

  • Switch to mania upon discontinuation of antidepressants in patients with mood disorders: a review of the literature. Ali, Sherese; Milev, Roumen // Canadian Journal of Psychiatry;May2003, Vol. 48 Issue 4, p258 

    Objective: To review the literature for reported cases of mania related to discontinuing antidepressant treatment, as well as for possible explanations of this phenomenon, and to present a case report.Method: We undertook a literature review through the PubMed index,...

  • Quetiapine: A Review of its Use in the Treatment of Bipolar Depression. Keating, Gillian M.; Robinson, Dean M. // Drugs;2007, Vol. 67 Issue 7, p1077 

    Quetiapine (Seroquel) is the only atypical antipsychotic approved in the US for use as monotherapy in both bipolar mania and depression, offering potential compliance advantages. Monotherapy with oral quetiapine 300 mg/day is effective in the treatment of patients with bipolar I or II...

  • Prophylactic lithium: a double-blind trial in recurrent affective disorders. Melia, P. I. // British Journal of Psychiatry;Jun70, Vol. 116 Issue 535, p621 

    The article discusses the results of a study, in which a double-blind trial of prophylactic lithium in recurrent affective disorders was performed. The study investigated the hypothesis that lithium reduces the frequency of manic and depressive episodes in patients with hitherto frequently...

  • Risk factors for the development of lithium-induced polyuria. Movig, K. L. L.; Baumgarten, R.; Leufkens, H. G. M.; Van Laarhoven, J. H. M.; Egberts, A. C. G. // British Journal of Psychiatry;Apr2003, Vol. 182, p319 

    Background: Polyuria is common in patients with bipolar disorder treated with lithium. However, the risk factors for polyuria in these patients have not been established.Aims: To estimate the prevalence of polyuria associated with the use of lithium and to identify...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics